Asia Insider

MiCA Regulation Continues To Be Implemented, And Anmrex Exchange Completes Adaptation While Strengthening Service Safeguards For Global Users

Asia Insider — Mon, 20 Jul 2026 09:24:16 +0000

Recently, as the Markets in Crypto-Assets Regulation (MiCA) of EU enters its continuous implementation phase, the European digital asset market is rapidly establishing unified, transparent, and standardized operating procedures. Discussions around market access, asset protection, information disclosure, and cross-border services continue to intensify, while regulatory focus is further shifting toward practical implementation and the protection of user rights and interests. In response to this trend, Anmrex Exchange has completed its adaptation to the MiCA regulation and has integrated the relevant requirements of the framework into platform governance, technical systems, and service standards, ultimately providing global users with clearer trading rules, more comprehensive asset protection, and a more stable digital asset service environment.

The implementation of MiCA not only affects the European market, but also reflects the accelerating institutionalization of global digital asset compliance. From North America and Europe to major financial markets in Asia, jurisdictions are tightening requirements related to customer identification, anti-money laundering management, risk control, asset security, and information disclosure. As rules become clearer, users can more easily understand the service scope, trading costs, and asset protection mechanisms of the platform, allowing them to manage accounts and trade digital assets within a more predictable environment.

At present, Anmrex has obtained a U.S. SEC compliance filing, a U.S. FinCEN MSB license, and a Polish VASP license, while continuously upgrading its operating system for global markets. These developments have further unified the platform standards in asset security, risk management, information disclosure, service specifications, and other areas, enabling users to obtain more transparent fee explanations, more complete product information, a smoother deposit and account management experience, and more timely and professional customer support.

Concurrently, Anmrex continues to advance its cross-regional compliance by pursuing relevant licensing frameworks, including the UK FCA, the MAS of Singapore, and the Securities Commission of Malaysia (specifically under the RMO and DAX frameworks). By strengthening institutional alignment among different jurisdictions, the platform is gradually unifying standards for asset protection, information disclosure, trading services, and customer support, enabling users in Europe, Southeast Asia, and other international markets to receive relatively consistent asset safeguards, trading environments, and professional support. As its global compliance layout continues to improve, Anmrex is also further strengthening its technical infrastructure and operational governance, providing a more solid institutional and technical foundation for international services.

iHerb Launches “718 Summer Limited-Time Offer” in Singapore

Asia Insider — Mon, 20 Jul 2026 03:00:00 +0000

SINGAPORE – Media OutReach Newswire – 20 July 2026 – Global health and wellness platform iHerb has launched its “718 Summer Limited-Time Offer” alongside a curated selection of products designed to support summer skincare needs in Singapore. The initiative reflects growing consumer interest in combining topical skincare with nutritional supplements as part of an inside-out approach to beauty and wellness.

The iHerb 718 Summer Limited-Time Offer includes a 25% discount for existing customers and a 30% discount for new customers

Organised around the three core needs of hydration, protection and repair, the selection spans inner care, sun protection, after-sun care and daily nutritional supplements, supporting a comprehensive approach to summer skincare.

As part of its summer campaign, iHerb is running a “718 Summer Limited-Time Offer” promotion until July 25 (11:59 PM). New customers can enter the promo code “26PRN7” at checkout to receive 30% off, while existing customers can use “26SUM77” to receive 25% off eligible purchases (terms & conditions apply).

Supporting Hydrated, Healthy-Looking Summer Skin from the Inside Out

To support skin hydration from within, iHerb’s in-house brand, California Gold Nutrition‘s “Hyaluronic Acid Complex,” combines hyaluronic acid, L-Proline, French grape seed extract and French maritime pine bark extract. The formula is a great choice for consumers seeking daily hydration and healthy-looking skin.
For Vitamin C supplementation, Doctor’s Best offers a daily source of Vitamin C with “Vitamin C with Q-C.” While Life Extension’s “BioActive Complete B-Complex“ provides a comprehensive blend of B vitamins to support the nutritional needs of consumers with busy and active lifestyles.

For a more enjoyable way to supplement daily nutrition, Nature’s Way “Alive! Hair, Skin & Nails Gummies“ comes in a strawberry-flavoured chewable format that makes supplementation easy.

Sun Protection and After-Sun Care for Summer

Sun protection and after-sun care are essential for maintaining healthy skin during the summer. think (Thinkbaby®) “Zinc Oxide Sunscreen, SPF 50” is formulated with zinc oxide and features a comfortable texture suitable for daily commutes, outdoor activities and family trips.

After sun exposure, Lily of the Desert’s “99% Aloe Vera Gelly“, made primarily with organic aloe vera, provides lightweight hydration and soothing care with a refreshing texture.

718 Summer Limited-Time Offer Details

Discover iHerb’s summer skincare essentials with exclusive savings available until July 25 (11:59 PM). New customers can enjoy 30% off eligible purchases with the promo code “26PRN7”, while existing customers can receive 25% off using “26SUM77”. Terms and conditions apply.

iHerb: A One-Stop Global Health and Wellness Platform

Headquartered in California, USA, iHerb is a global online retailer of health and wellness products. The platform provides Singapore consumers with access to authentic products through a safe and reliable cross-border shopping experience. Products are shipped directly from logistics centres in the US and Asia, alongside the following delivery and shipping options:

Fast Delivery: Orders can arrive in as fast as 3 days.
Free Shipping: Available on orders over SGD 30.

The 718 promotion and curated summer selection are available on iHerb Singapore.

Hashtag: #iHerb

https://sg.iherb.com

The issuer is solely responsible for the content of this announcement.

About iHerb

iHerb is a globally renowned US-based cross-border e-commerce platform specializing in high-quality health supplements, nutritional products, beauty and personal care, and daily essentials. Offering a curated selection of over 50,000 items and serving more than 180 countries and regions, iHerb is dedicated to helping global consumers access health and beauty options at reasonable prices. All products are shipped directly from multiple advanced logistics centers in the US and Asia, maintaining product freshness through rigorous cold-chain and temperature-controlled warehousing management. iHerb also continuously enhances its multi-language customer service and localized payment methods to ensure a safe, transparent, and convenient shopping experience for users worldwide

Imperial Harvest Unveils US$1.888 Million Mahjong Set in Singapore, With All Proceeds Pledged to Childhood Brain Cancer Research

Asia Insider — Mon, 20 Jul 2026 02:00:00 +0000

SINGAPORE – Media OutReach Newswire – 20 July 2026 – Imperial Harvest, an Imperial Feng Shui consultancy in Singapore, has unveiled a one-of-one bespoke mahjong set valued at US$1.888 million (approximately S$2.4 million) — placing it among the world’s most valuable mahjong sets ever created — with all proceeds from its sale pledged to DIPG Foundation Singapore, funding research into one of the deadliest childhood brain cancers.

Imperial Feng Shui Mahjong Set

For generations, mahjong has been far more than a pastime. Rich in symbolism, strategy and tradition, the centuries-old game has long brought families and friends together around a table, and today it is enjoying a global resurgence, winning new audiences across the United States and beyond.

Against this backdrop, the one-of-one creation brings together exceptional materials, artisanal craftsmanship and Imperial Feng Shui principles into a collector’s piece that channels cultural heritage into meaningful change.

Turning Prosperity Into Hope for Children

Diffuse Intrinsic Pontine Glioma (DIPG) is a rare and aggressive brain tumour that primarily affects children between the ages of five and 11, and has long been considered incurable. In 2024, doctors reported the world’s first case of a child effectively cured of DIPG, renewing global momentum in the field — yet research into the disease remains critically underfunded.

All proceeds from the sale of the mahjong set will be donated to DIPG Foundation Singapore, Singapore’s first foundation dedicated to advancing research into DIPG and other paediatric brain cancers. Founded by families who each experienced the loss of a child to the disease, the foundation supports research, advocates for greater access to innovative therapies and clinical trials, and provides resources for affected children and their families.

For Grand Master David Goh, founder of Imperial Harvest, donating the proceeds reflects a belief that prosperity carries its greatest meaning when it can be shared. The mahjong set celebrates abundance through symbolism and craftsmanship while channelling that value into research that brings hope to affected children and their families.

A Fading Craft, Reimagined

The set arrives at a time when the traditional art of mahjong tile carving is fading worldwide, lending its craftsmanship a significance beyond luxury alone. At the heart of the set are 156 playing tiles, including Animal, Fei and Joker tiles, individually crafted in untreated Burmese Grade A Black Jadeite. Revered for its rarity and cultural significance, the stone has long been associated with protection, resilience and prosperity, with every tile retaining its natural individuality.

The tiles are housed in a bespoke trunk wrapped in exceptionally rare Himalayan Niloticus crocodile leather, prized for its naturally occurring gradient reminiscent of snow-capped mountain peaks and sourced from a tannery that supplies some of the world’s most prestigious luxury maisons. Inside, aerospace-grade Alcantara — the same premium material found in the interiors of Ferrari and Lamborghini supercars — creates a soft, durable lining that protects every tile.

Where Feng Shui Meets Design

Guided by third-generation feng shui master Grand Master David Goh, every detail has been considered not only for its visual appeal but also for its symbolic significance, resulting in a collector’s piece that seeks to harmonise Heaven, Earth and humanity.

The conventional Singapore animal tiles have been replaced by the Four Celestial Guardians — the Azure Dragon, Vermilion Phoenix, White Tiger and Black Tortoise — mythical creatures deeply rooted in Chinese cosmology that traditionally represent protection, balance and harmony. Likewise, the flower tiles have been redesigned to depict four auspicious creatures: the bat, deer, crane and magpie, collectively symbolising fortune, prosperity, longevity and happiness.

Even one of mahjong’s most recognisable tiles, the Seven Dots, has been reimagined. Instead of following its conventional arrangement, the seven circles are positioned according to the “Seven Star Lighting” formation, an Imperial Feng Shui configuration believed to represent stability, clarity and strategic balance. The Character suit, meanwhile, features English transliterations such as “Yi Wan”, “Er Wan” and “San Wan”, making the set accessible to an international audience while preserving its cultural identity.

As Grand Master David Goh describes it, the set is “far beyond a Mahjong set. Every detail has been calibrated to harmonise Heaven, Earth and Man, ensuring that its owner engages not just in a game, but in a field of aligned opportunity, protection and infinite prosperity.”

A New Definition of Luxury

Whether viewed as a collector’s piece, a work of design or cultural heritage, the Imperial Feng Shui Mahjong Set occupies a category of its own — a reminder that the greatest luxury may ultimately be the opportunity to create meaningful change. It is a philosophy that Imperial Harvest carries through its bespoke Feng Shui consultation services in Singapore, where prosperity is understood as something to be built, and shared.

Hashtag: #ImperialHarvest #GrandMasterDavidGoh #ImperialHarvestMahjongSet #ImperialFengShui

https://imperialharvest.com/
https://www.instagram.com/imperialharvest/

The issuer is solely responsible for the content of this announcement.

About Imperial Harvest

Imperial Harvest is a Singapore-based luxury Imperial Feng Shui maison dedicated to empowering individuals with clarity, breakthroughs, and prosperity. Founded by Grand Master David Goh, Imperial Harvest upholds the royal Feng Shui traditions once reserved for Chinese emperors, making them accessible to modern professionals, business leaders, and families worldwide.

At the heart of Imperial Harvest is a unique blend of time-honoured metaphysics and contemporary craftsmanship. Every treasure – from fine jadeite and rare agarwood to bespoke jewellery collections – is carefully matched to each client’s Bazi chart and personally blessed by Grand Master David to activate favourable elements for wealth, benefactors, and opportunities.

With a proven track record of guiding thousands of clients to achieve career milestones, business growth, and lasting harmony, Imperial Harvest continues to set the benchmark for authentic, results-driven Imperial Feng Shui. The maison is committed to building lifelong partnerships grounded in trust, expertise, and transformational success.

International Conference of the Modernization of Chinese Medicine & Health Products (ICMCM) gathers global experts in Chinese Medicine

Asia Insider — Mon, 20 Jul 2026 02:00:00 +0000

Concurrent Food Expo features “Multi-Facets of Chinese Medicine” exhibition

HONG KONG SAR – Media OutReach Newswire – 20 July 2026 – The 25^th International Conference of the Modernization of Chinese Medicine and Health Products (ICMCM), organised by the Modernized Chinese Medicine International Association (MCMIA) together with the HKTDC and ten scientific research institutions, will be held from 13 to 15 August at the Hong Kong Convention and Exhibition Centre (HKCEC), offering industry professionals the latest insights into Chinese medicine. This year’s conference is funded by the Chinese Medicine Development Fund of the Government of the Hong Kong Special Administrative Region. It is dedicated to strengthening the ties between Hong Kong’s Chinese medicine industry and the international market, while promoting Hong Kong’s leading role in the global field of Chinese medicine.

Register for the conference to stay updated with the latest industry information on Chinese medicine: https://tinyurl.com/tmvryr38

Aligning with the strategic Blueprint with a focus on “Bringing In and Going Global”

The Chinese Medicine Development Blueprint of Hong Kong (the Blueprint) released in 2025 positions Hong Kong as a bridgehead for the global internationalisation of Chinese medicine and a key highland within the national framework for Chinese medicine development. To actively support the strategic direction of the Blueprint, this year’s conference adopts the theme Clinical Translation, Regulatory Policies and Global Innovative Pathways of Traditional Medicine, focusing on two core elements: bringing in and going global. It introduces Hong Kong’s Chinese medicine regulations and resource support to participants from Chinese Mainland and overseas, while inviting overseas regulatory authorities to share their local traditional medicine regulations. This year, some 30 experts and scholars from Hong Kong, Chinese Mainland, and overseas have been invited to comprehensively explore the latest research and development trends, regulatory interpretations, and success cases in Chinese medicine.

The three-day conference is divided into five major thematic sessions, covering policy blueprints, international regulations, clinical research, success case sharing, and talent cultivation:

The Chinese Medicine Development Blueprint of Hong Kong, development trends, and government support for the industry

To help enterprises from Chinese Mainland and abroad understand Hong Kong’s Chinese medicine regulation and support, Dr. Vincent Chung Chi-ho, Commissioner for Chinese Medicine Development, Chinese Medicine Unit, Health Bureau, will elaborate on the Blueprint, while Law Kwok-wai, Robert, Chief Pharmacist (Chinese Medicine), Chinese Medicine Regulatory Office, Department of Health, Dr. Yeung Kin Wai, Senior Chemist, Government Chinese Medicines Testing Institute, Department of Health, and Prof. Bian Zhaoxiang, Hospital Chief Executive, The Chinese Medicine Hospital of Hong Kong (CMHHK) , will share in-depth insights into the latest progress in Chinese medicine regulation, quality standards testing, and clinical practice and research at the Chinese Medicine Hospital. Furthermore, Arnold Lau, Associate Director-General, Invest Hong Kong, Dr. William Cheung, Deputy Chief Manager (Life and Health Technology), Office for Attracting Strategic Enterprises (OASES), Angela Yu, Deputy Head of Health Tech and TCM, Hong Kong Productivity Council and Wing Chu, Deputy Director of Research, HKTDC, will participate in a panel discussion to analyse the Hong Kong government’s resource support for the development of Chinese medicine.

International regulations and standards for Chinese medicine and traditional medicine

To provide attendees with a comprehensive analysis of market trends, Prof. Zheng Linyun, Executive Vice President of the Shanghai Academy of International Standardization of Traditional Chinese Medicine, will share reflections and prospects on the transformation of ISO/TC249. Furthermore, Prof. Taruna Ikrar, Chairperson of the Indonesian Food and Drug Authority (BPOM), Indonesia, Nurul Anisah Binti Shahri from National Pharmaceutical Regulatory Agency (NPRA), Ministry of Health, Malaysia and Thawatchai Nakkaratniyom, Senior Professional Level Pharmacist, Head of Pre-marketing Control Group, Herbal Products Division at Thai Food and Drug Administration, Ministry of Public Health, Thailand will jointly analyse the regulations and standards of the Southeast Asian market.

Traditional medicine and Chinese medicine development and clinical research

Scientific and clinical experts will share the latest progress in the scientific research and clinical application of Chinese medicine, as well as experiences regarding the R&D application and clinical efficacy of hospital-made Chinese medicine preparations. Prof. Zhang Zhongde, Deputy President of Guangzhou University of Chinese Medicine & President of Guangdong Provincial Hospital of Chinese Medicine will share Chinese Mainland’s practices in the research and development of Chinese medicine. Prof. Lee Sanghoon, Dean, International Education Institute of Korean Medicine, Kyung Hee University will discuss the development of new natural product drugs in Korea. Prof. Pei Xiaohua, Dean of Changping Hospital Affiliated to Beijing University of Chinese Medicine and Director of the Institute of Traditional Chinese Surgery will discuss clinical needs in developing new Chinese herbal medicines for TCM-advantageous breast diseases. Locally, Prof. Zhang Ge from Hong Kong Baptist University will present innovative achievements in utilising traditional Chinese medicine to drive target discovery for triple-negative breast cancer, while Prof. Xian Yanfang Lisa, Assistant Professor, School of Chinese Medicine, Faculty of Medicine, The Chinese University of Hong Kong will share pre-clinical and clinical studies of novel Chinese medicine formula for treating gout.

Sharing of success cases and experience in international Chinese medicine practitioner training

Focusing on successful industry practices, ICMCM provides an interactive platform for the industry, helping to ensure the continuous development and growth of the traditional Chinese medicine sector. Yan Han, Chairman, Beijing Tong Ren Tang Chinese Medicine Company Limited will share the cultural heritage and internationalised development of Chinese medicine, and Dr. Celine Cheng, Chief Compliance & Technology Officer of Jacobson Pharma Corporation Limited will share GMP applications in the industry. Several professors from Chinese Mainland, Australia, Canada, Macao, and Singapore—including Prof. Li Min, Dean and Chair Professor, School of Chinese Medicine, Hong Kong Baptist University; Prof. Xu Hongxi, Chairman, Belt and Road Alliance for Traditional Medicine, Honorary Dean & Distinguished Professor, Shanghai University of Traditional Chinese Medicine; Prof. Zhu Xiaoshu, Co-Director, Australia-China Chinese Medicine Centre, Western Sydney University, Australia; and Prof. Linda Zhong, Director, Biomedical Sciences and Chinese Medicine, School of Biological Sciences, Nanyang Technological University, Singapore —will explore training models for Chinese medicine talent at home and abroad, alongside market demands for Chinese medicine products in potential markets.

Talent cultivation: The 22^nd International Postgraduate Symposium on Chinese Medicine

The Symposium will be held on the morning of 15 August. This year, it is jointly organized by eight institutions, including four Hong Kong universities—The Chinese University of Hong Kong, The University of Hong Kong, Hong Kong Baptist University, and The Hong Kong University of Science and Technology—alongside Nanyang Technological University in Singapore, the University of Macau, Shanghai University of Traditional Chinese Medicine, and Guangzhou University of Chinese Medicine. The Symposium will kick off with Vincent & Lily Woo Fellowship in Memory of Dr Albert Wong endowed by Vincent & Lily Woo Foundation Award Presentation Ceremony, hosted by the Modernized Chinese Medicine International Foundation. This year’s Symposium will feature nearly 100 research presentations, including oral research presentations by 10 postgraduate students from Hong Kong, Chinese Mainland, Australia, Singapore, South Korea, Vietnam, and Serbia, and nearly 90 poster displays. The judging panel will select 10 winners for the Tianjiang Cup Li Shizhen Youth Outstanding Thesis Award. The Symposium not only provides a platform for postgraduate students in Chinese medicine to share their research progress and achievements but also promotes student collaboration and exchange, laying an important cornerstone for cultivating a new generation of scientific research professionals and driving the development of Chinese medicine.

This year’s conference continues to operate under the hybrid model, with simultaneous interpretation in both English and Putonghua offered to enable wider industry participation.

Concurrent Food Expo features “Multi-Facets of Chinese Medicine” exhibition and ICMCM Public Forum to promote public education

In addition to the professional conference tailored for industry practitioners, ICMCM is committed to promoting the popularisation and implementation of Chinese medicine in the community through a public education display area titled “Multi-Facets of Chinese Medicine” at the concurrent Food Expo. In response to the directives of the Blueprint, this interactive and educational display aims to significantly enhance the public’s correct understanding of and confidence in Chinese medicine.

The design of the exhibition is closely aligned with the development direction set out in the Blueprint, providing a comprehensive overview of the new chapter in Hong Kong’s Chinese medicine sector. It covers four main themes including the latest development trends of Chinese medicine in Hong Kong, the service features of the Chinese Medicine Hospital of Hong Kong, the Hospital Authority’s Chinese medicine outpatient services, Chinese medicine regulation framework and Chinese medicine practitioner registration system, alongside knowledge on Chinese medicine wellness practices.

A half-day ICMCM Public Forum will be held on Saturday, 15, August 2026, to promote the advantages of Chinese medicine services, interesting Chinese medicine wellness tips and preventive healthcare. By running industry conferences alongside public exhibitions and forums in parallel, the event aims, on the one hand, to foster academic and industrial innovation exchanges among global Chinese medicine experts, and on the other, to embed Chinese medicine culture deeply into the daily lives of the public, thereby jointly promoting Hong Kong’s development as an international centre for Chinese medicine.

Conference programme: icmcm.hktdc.com/pdf/2026/programme.pdf
Website: hktdc.com/icmcm

Concurrent Exhibitions:
HKTDC Food Expo PRO foodexpopro.hktdc.com
HKTDC Hong Kong International Tea Fair hkteafair.hktdc.com
HKTDC Food Expo hkfoodexpo.hktdc.com
HKTDC Beauty & Wellness Expo hkbeautyexpo.hktdc.com
HKTDC Home Delights Expo homedelights.hktdc.com

Hashtag: #HKTDC #ICMCM

The issuer is solely responsible for the content of this announcement.

NIA Spotlights Thailand’s Wellness Boom as Global Consumers Spend Boundlessly on Longevity

Asia Insider — Mon, 20 Jul 2026 02:00:00 +0000

Deep dive into the DNA of Thailand’s wellness giants—BDMS Wellness Clinic and Chiva-Som—and their strategic blueprints to transform the kingdom into the ultimate global wellness destination.

BANGKOK, THAILAND – Media OutReach Newswire – 20 July 2026 – In the modern era, “good health” has redefined the meaning of true wealth. Consumers worldwide are now heavily investing in innovations that promote longevity and extend healthspan—the period of life spent in good health. Even amid economic uncertainty, health and well-being remain top priorities for consumers. This behavioral shift helping drive the global wellness economy to a reached USD 6.8 trillion in 2024, representing a 7.9% growth from the previous year. Furthermore, the Global Wellness Institute (GWI) projects the market to surge to USD 9.8 trillion by 2029, maintaining an average annual growth rate of 7.6%. Driven by this exponential growth, nations worldwide, including Thailand, are aggressively developing wellness services and innovations to serve as a “New Growth Engine” and a key indicator of long-term national competitiveness.

NIA Spotlights Thailand’s Wellness Boom

Where Does Thailand Stand in the Global Health & Wellness Industry?

When evaluating Thailand’s potential, Thailand ranks among the world’s leading healthcare destinations. According to the Numbeo Health Care Index 2026, Thailand’s healthcare system is ranked 8th globally, making it the sole ASEAN nation to secure a spot in the Top 10. Focusing specifically on the health and wellness sector, Thailand achieved the highest growth rate globally in 2023, with the market value soaring past USD 40 billion—a remarkable 28.4% increase. The “Wellness Tourism” segment alone skyrocketed by 36.4%, outperforming the global average by threefold.

These figures reflect much more than financial profits; they underscore Thailand’s robust readiness and distinct advantages. The country boasts world-class medical infrastructure, accredited hospitals, highly skilled medical professionals, reasonable treatment costs, and an established reputation as a top wellness destination. Additionally, Thailand possesses unique cultural assets—such as traditional Thai herbs, Thai massage, healthy cuisine, and medical tourism—that can be strategically leveraged into a high-value economy.

Driving a High-Income Economy with Deep Tech in the Wellness Market

Prof. Dr. Yodchanan Wongsawat, Deputy Prime Minister and Minister of Higher Education, Science, Research and Innovation (MHESI), announced a strategic vision to transform Thailand’s wellness industry from traditional services into a high-value, globally competitive innovation sector. The strategy aims to unlock the potential of Thai culture, local wisdom, and rich biodiversity by implementing modern science and technology to establish evidence-based efficacy. Furthermore, cutting-edge innovations such as Health Tech, Artificial Intelligence (AI), and Machine Learning (ML) will be deployed to analyze deep health data. Equipping the sector with Deep Tech will significantly elevate international credibility.

Prof. Dr. Yodchanan emphasized: “MHESI is fully prepared to act as a vital gear in mitigating R&D investment risks for the private sector through an end-to-end support system. We aim to accelerate the commercialization of Thai innovations by systematically connecting the innovation ecosystem. This includes matchmaking entrepreneurs, startups, researchers, and universities, alongside injecting comprehensive financial and resource support. Our assistance spans R&D grants, advanced laboratory access, clinical trials, global production standard upgrades, and intellectual property protection. Collectively, these mechanisms will propel wellness into a New Growth Engine, boosting national competitiveness and establishing Thailand as a true global wellness hub.”

NIA’s Four Strategic Pillars to Propel the Thai Wellness Economy Globally

Dr. Krithpaka Boonfueng, Executive Director of the National Innovation Agency (NIA), stated that driving the wellness industry sustainably cannot be achieved by the private sector alone. It requires cross-sector collaboration to foster an innovation ecosystem conducive to research, technological development, standard testing, and global market expansion. The NIA has continuously supported entrepreneurs in health, wellness, and medical technology through capacity-building initiatives like the Wellness Academy, startup incubation, university network integration, and innovation competitions to translate ideas into market-ready businesses.

The NIA prioritizes data, research, and scientific evidence to build trust and add value to Thai wellness products and services. Simultaneously, the agency connects entrepreneurs to vital resources and innovation networks to stimulate the healthcare economy, creating jobs and new revenue streams through four key strategies:

Connecting Innovative Businesses: Fostering synergies across the ecosystem.
Upgrading Wellness Establishments and Labor Skills: Elevating service standards and workforce capabilities to international levels.
Driving Progress via Thailand Innovation Hubs: Utilizing regional hubs to stimulate localized innovation.
Scaling Up and Building International Recognition: Enhancing global awareness of Thai wellness as credible, safe, verifiable, and uniquely high-value.

The NIA’s ultimate goal is not merely to create new innovative businesses, but to build a sustainable ecosystem that empowers Thai entrepreneurs to grow robustly and integrate seamlessly into the global health and wellness supply chain.

BDMS Champions “Healthspan” and Preventive Medicine to Secure a Competitive Edge

As longevity becomes a primary aspiration for the global population, BDMS Wellness Clinic—a premier wellness leader in Thailand—is accelerating the preventive healthcare industry. By utilizing health science and personalized medicine, the clinic designs deep-level bodily care to firmly establish Thailand as a pioneer in modern health trends.

Dr. Tanupol Virunhagarun, Chief Executive Officer of BDMS Wellness Group, Bangkok Dusit Medical Services Public Company Limited (BDMS), highlighted that transitioning from treating illnesses to preventing them is an undeniable global megatrend. This aligns with World Health Organization (WHO) data indicating that every 1 Baht invested in wellness yields up to a 35-fold return by reducing public healthcare expenditures and enhancing citizen quality of life. This expertise has positioned BDMS Wellness Clinic as a major private-sector anchor, attracting high-spending global consumers to Thailand through its concept of “Scientific Wellness.” This approach features evidence-based healthcare, ranging from advanced genetic testing and personalized nutrition and vitamin formulations to blending modern medical innovations with traditional Thai medicine for verifiable results. Upgrading these standards shifts Thailand’s image from a leisure destination to a highly credible, advanced medical hub, serving as a crucial mechanism in partnering with the government to promote the nation as “Wellness Hub Thailand, The Land of Life” and a top-of-mind Global Wellness Destination.

Chiva-Som Showcases the “Thai Spirit” to Redefine the Health Economy

Complementing advanced medical dimensions, Thailand possesses iconic brands in health tourism marketing, such as Chiva-Som—the country’s first wellness resort and a pioneer in Asia. Spanning over three decades, Chiva-Som evolved from a modest beachfront holiday home in Hua Hin into one of the world’s top wellness resorts, capturing the loyalty of high-net-worth consumers from the West. What sets Chiva-Som apart is not just its world-class international treatments, but the “Thai spirit of hospitality”—characterized by humility, gentleness, and sincerity—seamlessly integrated with a profound understanding of holistic wellness.

Drawing from this tangible success, Mr. Krod Rojanastien, Consultant to President of Chiva-Som International Health Resort Co., Ltd., shared a pivotal insight: In a digital era where people face chronic stress and burnout, wellness has become mainstream. Thailand holds a distinct competitive advantage through its innate service spirit, gentle culture, and centuries-old traditional Thai medical wisdom. Moving forward, the priority must be backing this traditional wisdom with scientific research to secure international trust. Thailand’s future marketing goal must transcend being a temporary vacation spot; it must elevate into a global “Sanctuary” where people intentionally travel to restore their body, mind, and overall quality of life.

When science, technology, innovation, and Thai wisdom are systematically woven together, the wellness economy will transform from a mere service sector into a powerful economic engine. It will lead Thailand toward becoming a definitive Global Wellness Destination, generating economic wealth and holistic well-being simultaneously.
Hashtag: #NIA #NationalInnovationAgency

https://www.nia.or.th/

The issuer is solely responsible for the content of this announcement.

Crypto News Today: AlphaPepe Presale Nears Sell Out As Bitcoin Price Prediction Eyes $200,000

Asia Insider — Mon, 20 Jul 2026 01:15:00 +0000

MONACO CITY, Monaco, July 19, 2026 (GLOBE NEWSWIRE) — Crypto news today is turning toward the next major market cycle as Bitcoin price prediction forecasts begin discussing whether BTC could eventually reach $200,000. Bitcoin remains the market leader, but its size is also pushing traders to examine earlier-stage crypto opportunities before public-market price discovery begins.

AlphaPepe is entering that conversation as its presale moves closer to selling out. The project has now raised more than $2 million, attracted over 10,300 holders, and reached a current presale price of $0.02158.

Launch preparations are underway, a second independent audit has been secured through Coinsult with a high score, and the team has confirmed that details of a fourth centralized exchange partnership will be announced soon.

AlphaPepe Presale Passes $2M as Final Window Tightens

AlphaPepe has now raised more than $2 million and built a community of over 10,300 holders before its exchange launch.

The current $ALPE presale price is $0.02158. That price remains fixed during the active stage, but it will not remain available once the remaining allocation closes.

This is where the urgency begins. Three CEX partnerships have already been announced, a fourth is coming soon, and the project is moving through launch preparations while buyers can still enter before open-market trading begins.

Once $ALPE reaches public price discovery, liquidity, exchange activity and market demand will determine the price.

Second Coinsult Audit Strengthens the Launch Setup

AlphaPepe has completed its second independent audit through Coinsult and received a high audit score.

The review adds another layer of external security assessment around the $ALPE token and its smart-contract infrastructure. It also gives prospective buyers more information to examine before participating in the presale.

AlphaSwap AI DEX Remains the Core Product Story

AlphaPepe is being developed as more than a standalone meme coin. The project already has AlphaSwap Early Access live, giving users an early look at its AI-powered decentralized exchange ecosystem supported by the $ALPE token.

AlphaSwap combines decentralized token trading with AI-assisted tools designed to help users assess market conditions, review token risks and make more informed decisions before executing a swap.

AlphaRouter is now being developed as the advanced routing layer behind the exchange. It will compare multiple liquidity paths before a transaction is completed, helping AlphaSwap identify more efficient routes and improve execution across available pools.

Cross-chain bridging is expected to follow after AlphaRouter goes live, allowing AlphaSwap to expand beyond single-chain trading and connect users with liquidity across additional blockchain networks.

Fourth CEX Partnership Announcement Coming Soon

AlphaPepe has already announced three centralized exchange partnerships, and the team has confirmed that a fourth partnership announcement is coming soon.

The exchange has not yet been named publicly. Buyers should rely only on AlphaPepe’s official website and verified social channels until the full announcement is released.

FINAL30 Gives Buyers 30% Extra Tokens

AlphaPepe has activated a limited-time offer while launch preparations are underway.

Buyers purchasing $100 or more can use promo code FINAL30 to receive 30% extra $ALPE tokens. The bonus is added to the standard token allocation available through an eligible purchase.

The FINAL30 campaign is available only for a limited period and may end as AlphaPepe moves closer to completing the presale.

Bitcoin Price Prediction and the Road to $200,000

Bitcoin price prediction forecasts continue to examine whether BTC could eventually reach $200,000 during another major market expansion.

The target remains speculative and would require sustained institutional demand, stronger global liquidity and enough new capital to move Bitcoin toward a market valuation of roughly $4 trillion.

Bitcoin still offers the strongest liquidity, recognition and market history in crypto. However, its size changes the percentage-upside equation.

AlphaPepe is operating at a different point in the cycle. Bitcoin already has a global chart, established liquidity and visible resistance levels. AlphaPepe remains in presale before public-market price discovery begins.

AlphaPepe Moves Toward Public Price Discovery

AlphaPepe has raised more than $2 million, passed 10,300 holders, completed its second Coinsult audit and confirmed that a fourth CEX partnership announcement is approaching.

The presale price remains $0.02158, but the window is closing as launch preparations move forward.

Eligible buyers purchasing $100 or more can use promo code FINAL30 to receive 30% extra tokens while the limited-time campaign remains active.

VISIT ALPHAPEPE OFFICIAL WEBSITE

FAQs

What is the Bitcoin price prediction for $200,000?
Bitcoin could potentially reach $200,000 if institutional demand, market liquidity and wider adoption continue to grow. The target remains speculative and would require Bitcoin to reach a market value of roughly $4 trillion.

Is the AlphaPepe presale closing soon?
Yes. AlphaPepe has raised more than $2 million, passed 10,300 holders and is moving through launch preparations. The current price is $0.02158, while purchases of $100 or more can receive 30% extra tokens using promo code FINAL30 for a limited time.

Contact:
Jack Duffy
contact@alphapepe.io

Disclaimer: This content is provided by AlphaPepe. The statements, views, and opinions expressed in this content are solely those of the content provider and do not necessarily reflect the views of this media platform or its publisher. We do not endorse, verify, or guarantee the accuracy, completeness, or reliability of any information presented. We do not guarantee any claims, statements, or promises made in this article. This content is for informational purposes only and should not be considered financial, investment, or trading advice. Investing in crypto and mining-related opportunities involves significant risks, including the potential loss of capital. It is possible to lose all your capital. These products may not be suitable for everyone, and you should ensure that you understand the risks involved. Seek independent advice if necessary. Speculate only with funds that you can afford to lose. Readers are strongly encouraged to conduct their own research and consult with a qualified financial advisor before making any investment decisions. However, due to the inherently speculative nature of the blockchain sector—including cryptocurrency, NFTs, and mining—complete accuracy cannot always be guaranteed. Neither the media platform nor the publisher shall be held responsible for any fraudulent activities, misrepresentations, or financial losses arising from the content of this press release. In the event of any legal claims or charges against this article, we accept no liability or responsibility. Globenewswire does not endorse any content on this page.

Legal Disclaimer: This media platform provides the content of this article on an “as-is” basis, without any warranties or representations of any kind, express or implied. We assume no responsibility for any inaccuracies, errors, or omissions. We do not assume any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information presented herein. Any concerns, complaints, or copyright issues related to this article should be directed to the content provider mentioned above.

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/30707cf6-b64d-4424-88ea-2dc2ba20ebd8

Academia Launches Dedicated IB Department to Support High-Performance IB English Outcomes in Singapore

Asia Insider — Mon, 20 Jul 2026 01:00:00 +0000

SINGAPORE – Media OutReach Newswire – 20 July 2026 – Academia Pte Ltd has announced the launch of its dedicated International Baccalaureate (IB) Department, marking a strategic expansion to support the growing number of IB Diploma Programme (IBDP) students in Singapore seeking specialised English training aligned with IB assessment standards.

Academia Education reception counter

The new department will focus initially on IB English Language & Literature and IB English Literature for Diploma Programme Year 1 and Year 2 students. The programme is designed to provide structured preparation for key IB assessment components, including Paper 1 (unseen textual analysis, including multimodal and visual texts), Paper 2 (comparative literary analysis), and the Individual Oral (IO), with optional support available for the Extended Essay.

The department launches with immediate effect, with rolling intake now open for small-group classes held at Tanglin Community Club (Whitley Road) and Upper Thomson. Each term runs for 12 weeks, with two-hour weekly sessions conducted in groups capped at 6–10 students.

The launch reflects growing demand among IB families for English training designed specifically around IB performance criteria, rather than general English tuition.

Addressing a Growing Need Among IB Families

Singapore is home to 41 IB World Schools, with more than 4,500 students sitting the IBDP examinations in 2025 across the May and November sessions. Schools offering the IB Diploma include ACS (Independent), St Joseph’s Institution, SJI International, Hwa Chong International, UWCSEA, Singapore American School, GIIS, Canadian International School, Stamford American International School, and Tanglin Trust School.

The country has consistently produced some of the strongest IB outcomes globally. In the November 2024 IB Diploma examinations, Singapore students achieved an average score of 38.4 points, significantly higher than the global average of 29.2 points. An IB score above 38 is widely regarded as equivalent to three A grades at A-Level under the UK UCAS framework.

Within this context, IB English often emerges as a key differentiator in overall Diploma scores, particularly for students aiming to achieve top-band results.

Dedicated IB-Specific Training

Academia’s IB Department is structured around component-based training aligned with official IB marking criteria, providing students with a repeatable method for approaching IB assessments.

The programme combines:

Structured preparation for Paper 1, Paper 2, and the Individual Oral
Analysis of literary, non-literary, and multimodal texts
Development of comparative literary argumentation
Training in critical literacy and rhetorical analysis
Optional guidance for the IB Extended Essay

Classes are designed to support students aiming for high-performance outcomes, particularly those targeting a score of 6 or 7 in IB English.

Leadership with Extensive IB Experience

The IB Department is headed by Mr Azrael Tseng, an educator with more than 20 years of teaching experience. His career includes seven years with Singapore’s Ministry of Education as well as experience teaching within international school IB environments. Over the course of his career, he has taught students who have gone on to achieve the maximum 45 points in the IB Diploma.

According to Academia, the department’s curriculum is developed by educators with strong academic backgrounds in English Language and Literature at the university and postgraduate levels. The programme emphasises analytical depth and intellectual range through engagement with a diverse set of global literary and non-literary texts.

Small-Group Structure and Performance-Focused Training

Classes are intentionally kept small, with enrolment capped at 6–10 students per group, enabling close feedback and sustained engagement with student writing.

The programme also incorporates elements of metacognitive and performance training, helping students develop structured thinking processes and confidence when responding to complex texts under examination conditions.

This approach is designed to address a common challenge for IB students: translating strong analytical ideas into consistently high-scoring responses within the time pressures of the IB exam format.
Hashtag: #Academia

https://academia.com.sg/
https://sg.linkedin.com/company/academiasg
https://www.facebook.com/academia.com.sg/
https://www.instagram.com/academia.com.sg/
https://www.youtube.com/channel/UCen95DWcBTx8G0-QduoYlAg

The issuer is solely responsible for the content of this announcement.

About Academia Pte Ltd

Academia is Singapore’s top-performing English, Literature, and General Paper tuition centre, offering structured, academically rigorous programmes for Primary, Secondary, and JC students. Founded by educators with global credentials, we specialise in developing thinkers, writers, and confident communicators. Our curriculum blends clarity, structure, and critical thought, designed to help students excel in the PSLE, O Levels, and A Levels. Weaving elements from the local education system with strategies re-engineered from top higher educational institutions and liberal arts colleges, our programme intelligently responds to your needs. We create empowered, smart and confident individuals who can navigate and dominate their future careers.

LUCID DEADLINE: ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Lucid Group, Inc. Investors to Secure Counsel Before Important July 28 Deadline in Securities Class Action – LCID

Asia Insider — Mon, 20 Jul 2026 00:12:00 +0000

NEW YORK, July 19, 2026 (GLOBE NEWSWIRE) —

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Lucid Group, Inc. (NASDAQ: LCID) between February 25, 2026 and April 13, 2026, inclusive (the “Class Period”), of the important July 28, 2026 lead plaintiff deadline.

SO WHAT: If you purchased Lucid securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the Lucid class action, go to https://www.rosenlegal.com/cases/lucid-group-inc-2026/join or call Phillip Kim, Esq. toll-free at 866-767-3653 or email case@rosenlegal.com for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than July 28, 2026. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered billions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers.

DETAILS OF THE CASE: According to the lawsuit, throughout the Class Period, defendants made false and/or misleading statements and/or failed to disclose that: (1) a supplier quality issue had significantly disrupted deliveries of the Lucid Gravity; (2) the foregoing was likely to, and did, have a material negative impact on Lucid’s business and financial results; (3) accordingly, the defendants had overstated the purported enhancements to Lucid’s manufacturing and delivery capabilities and overall operations; and (4) as a result, defendants’ public statements were materially false and misleading at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the Lucid class action, go to https://www.rosenlegal.com/cases/lucid-group-inc-2026/join or call Phillip Kim, Esq. toll-free at 866-767-3653 or email case@rosenlegal.com for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

——————————-

Contact Information:

        Laurence Rosen, Esq.
        Phillip Kim, Esq.
        The Rosen Law Firm, P.A.
        275 Madison Avenue, 40th Floor
        New York, NY 10016
        Tel: (212) 686-1060
        Toll Free: (866) 767-3653
        Fax: (212) 202-3827
        case@rosenlegal.com
        www.rosenlegal.com

Pudu Robotics Showcases Full Product Portfolio at WAIC 2026, Winning the “Most Investor-Attractive Enterprise” Award

Asia Insider — Sun, 19 Jul 2026 11:00:00 +0000

SHANGHAI, July 19, 2026 /PRNewswire/ — Pudu Robotics, a global leader in commercial service robotics, is showcasing its full portfolio of intelligent robotics solutions at the 2026 World Artificial Intelligence Conference (WAIC), held from July 17–20 in Shanghai. A key highlight of this year’s exhibition is the offline global debut of the PUDU D7, Pudu’s next-generation semi-humanoid robot. In tandem with its exhibition highlights, Pudu Robotics was also honored with the 36Kr "Most Investor-Attractive AI & Embodied Intelligence Enterprise" Award, recognizing the company’s growing influence in the embodied AI sector and continued confidence from the investment community.

Full Product Matrix on Display: Demonstrating Multi-Scenario Capabilities

Pudu’s comprehensive presentation at WAIC 2026 showcased its complete technical and product layout, spanning service delivery, commercial cleaning, industrial delivery, and general embodied intelligence.

The PUDU D5 quadruped robot demonstrates advanced terrain adaptability and autonomous navigation across an on-site obstacle course mimicking sand, gravel, steps, and slopes, simulating autonomous inspections in complex environments such as power substations and industrial parks. Additionally, the D5 performed high-speed "drifting" demonstrations at the booth, reaching peak speeds of up to 5 m/s and showcasing industry-leading mobility and responsiveness.

Making its global offline public debut, the PUDU D7 engaged visitors with several immersive and interactive live experiences. Attendees posed for photos with the D7, instantly receiving unique snapshots taken directly from a "robotics perspective." The robot also demonstrated advanced multi-robot coordination by autonomously walking and guiding the PUDU D5 quadruped around the booth while seamlessly avoiding pedestrian traffic, vividly illustrating collaborative workflows between different robotic form factors.

Pudu Robotics Product Portfolio at WAIC 2026

Pudu is also exhibiting its mature commercial robotics portfolio, including the BellaBot service delivery robot, the PUDU T300 industrial delivery robot, and the PUDU MT1 Max and PUDU CC1 Pro commercial cleaning robots. Together, these products highlight Pudu’s proven deployments across hospitality, retail, F&B, manufacturing, warehousing, and other industries.

Winning the "Most Investor-Attractive Enterprise" Award Amid Sustained Capital Traction

The "Most Investor-Attractive Enterprise" award from 36Kr arrives alongside sustained backing from major global institutional investors. In April 2026, Pudu Robotics completed a new financing round of nearly USD 150 million, bringing its valuation to more than USD 1.5 billion. This brings Pudu’s cumulative funding to more than USD 300 million.

This strong capital interest is supported by concrete commercial performance. According to the "2025 Global Embodied Intelligence and Commercial Service Robotics Independent Market Research Report" released by Frost & Sullivan, Pudu Robotics accounts for 25% and 23% of the global commercial service robotics market in terms of revenue and shipments respectively, ranking No. 1 worldwide in both categories. Furthermore, Pudu Robotics has maintained a year-over-year revenue growth rate exceeding 100%, with international markets accounting for more than 80% of total revenue for consecutive years. While the broader Embodied AI industry remains in early exploratory phases, Pudu has approached a positive EBITDA, achieving large-scale commercial viability ahead of the market.

From Product Export to Ecosystem Integration: A Blueprint for Global Expansion

According to the Research Report on Chinese Enterprises’ Overseas Expansion from 2025 to 2026 published by the 36Kr Research Institute, Pudu Robotics was featured as a primary benchmark case study for Embodied AI. The report attributes Pudu’s international success to its systematic combination of technological innovation, product capabilities, and localized global operation. Analysts noted that Pudu has successfully transitioned from exporting products to exporting global brand equity and integrated robotics ecosystems, establishing a core reference blueprint for hard-tech global expansion.

By deploying versatile product forms that span specialized, semi-humanoid, and humanoid forms, Pudu Robotics continues to focus on integrating Embodied AI directly into real-world environments—transforming Physical AI from a technical concept into a practical productivity partner.

About Pudu Robotics

Pudu Robotics, a global leader in the commercial service robotics sector, is dedicated to empowering easier work and better lives through AI and robotics, with a vision of building a global intelligent robotics infrastructure that serves 10 billion people worldwide.

Pudu Robotics has developed key core technologies and components, including robotic joint modules and motion controllers, and has filed more than 1,900 patent applications worldwide. Built on three core technologies—Embodied Navigation, Embodied Manipulation, and Embodied Interaction—Pudu Robotics has pioneered a "One Brain, Multiple Embodiments" architecture, establishing a comprehensive product portfolio that includes specialized, semi-humanoid, and humanoid robots.

Currently, Pudu offers four major product lines: service delivery, commercial cleaning, industrial delivery and general embodied AI. Its solutions are widely deployed across industries such as retail, hospitality, manufacturing, real estate and property services, healthcare, entertainment and sport, education, and public services.

To date, Pudu Robotics has shipped over 130,000 units globally, with a presence in more than 85 countries and regions.

ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Erasca, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – ERAS

Asia Insider — Sat, 18 Jul 2026 23:56:00 +0000

NEW YORK, July 18, 2026 (GLOBE NEWSWIRE) —

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Erasca, Inc. (NASDAQ: ERAS) between January 14, 2025 and April 26, 2026, inclusive (the “Class Period”), of the important August 10, 2026 lead plaintiff deadline.

SO WHAT: If you purchased Erasca common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the Erasca class action, go to https://rosenlegal.com/cases/erasca-inc/join or call Phillip Kim, Esq. toll-free at 866-767-3653 or email case@rosenlegal.com for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than August 10, 2026. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually handle securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered billions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers.

DETAILS OF THE CASE: According to the lawsuit, Erasca, Inc., along with its CEO and CFO, violated federal securities laws by making false and misleading statements about its lead oncology drug candidate, ERAS-0015, throughout the Class Period. According to the complaint, Erasca repeatedly touted ERAS-0015 as a potential “best-in-class” therapy and highlighted purportedly superior preclinical results compared to Revolution Medicines’ competing drug candidate, RMC-6236, while failing to disclose that those comparisons were allegedly improper, exposed Erasca to patent and trade secret disputes, and lacked a reasonable basis. When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the Erasca class action, go to https://rosenlegal.com/cases/erasca-inc/join or call Phillip Kim, Esq. toll-free at 866-767-3653 or email case@rosenlegal.com for information on the class action.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

——————————-

Contact Information: